• Phone+46462220758

Unit profile

This project aims to develop incretin therapy as a glucose-reducing strategy in type 2 diabetes (T2D). Its particular focus is to understand the mechanisms of incretin therapy and to optimize its clinical positioning. This mission is achieved by an interdisciplinary approach with complementary studies in subjects with T2D, healthy volunteers and experimental animals.

UKÄ subject classification

  • Endocrinology and Diabetes


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or